REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $245,560,740 | +11.2% | 8,871,414 | +7.4% | 0.01% | +16.7% |
Q2 2023 | $220,891,230 | +36.6% | 8,257,616 | +10.6% | 0.01% | +20.0% |
Q1 2023 | $161,708,665 | +3.2% | 7,465,774 | +13.5% | 0.01% | 0.0% |
Q4 2022 | $156,639,036 | +25.0% | 6,575,946 | +3.5% | 0.01% | +25.0% |
Q3 2022 | $125,291,000 | +19.0% | 6,353,459 | +17.6% | 0.00% | +33.3% |
Q2 2022 | $105,319,000 | -22.7% | 5,403,804 | +1.2% | 0.00% | -25.0% |
Q1 2022 | $136,230,000 | -1.1% | 5,340,288 | -2.5% | 0.00% | 0.0% |
Q4 2021 | $137,811,000 | -1.9% | 5,475,219 | +7.2% | 0.00% | 0.0% |
Q3 2021 | $140,466,000 | -8.1% | 5,106,038 | +6.0% | 0.00% | 0.0% |
Q2 2021 | $152,928,000 | -13.0% | 4,818,130 | +25.8% | 0.00% | -20.0% |
Q1 2021 | $175,770,000 | +26.4% | 3,831,074 | +9.1% | 0.01% | +25.0% |
Q4 2020 | $139,043,000 | +57.5% | 3,512,087 | +38.5% | 0.00% | +33.3% |
Q3 2020 | $88,266,000 | +152.7% | 2,536,410 | +129.3% | 0.00% | +200.0% |
Q2 2020 | $34,924,000 | +99.7% | 1,106,238 | +38.6% | 0.00% | 0.0% |
Q1 2020 | $17,490,000 | – | 798,257 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |